ClinicalTrialsFinder

High Risk of Recurrence Clinical Trials in Guangzhou, China/Guangdong

1 recruitingGuangzhou, China/Guangdong, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer

Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University40 enrolled1 locationNCT06280508